Co-Authors
This is a "connection" page, showing publications co-authored by Gabriella Fabbrocini and Maddalena Napolitano.
Connection Strength
5.303
-
Safety of dupilumab in atopic patients during COVID-19 outbreak. J Dermatolog Treat. 2022 Feb; 33(1):600-601.
Score: 0.888
-
Skin rashes after SARS-CoV-2 vaccine: which relationship, if any? Immun Inflamm Dis. 2021 09; 9(3):622-623.
Score: 0.238
-
Coronavirus disease and dermatology: current and future challenges. G Ital Dermatol Venereol. 2020 Oct; 155(5):683-684.
Score: 0.227
-
Biologics for psoriasis in COVID-19 era: What do we know? Dermatol Ther. 2020 07; 33(4):e13467.
Score: 0.222
-
Is climate change the next pandemic for dermatology? Lessons from COVID-19. Dermatol Ther. 2020 Jul; 33(4):e13682.
Score: 0.222
-
The role of occupational dermatology in the COVID-19 outbreak. Contact Dermatitis. 2020 08; 83(2):174-175.
Score: 0.221
-
Dupilumab and COVID-19: What should we expect? Dermatol Ther. 2020 Jul; 33(4):e13502.
Score: 0.221
-
COVID-19, quarantine, and atopic dermatitis. Med Hypotheses. 2020 10; 143:109852.
Score: 0.221
-
Reply: Potential role of Janus kinase inhibitors in COVID-19. J Am Acad Dermatol. 2020 07; 83(1):e65.
Score: 0.220
-
May IL-17 have a role in COVID-19 infection? Med Hypotheses. 2020 07; 140:109749.
Score: 0.220
-
Allergic contact dermatitis in patients with atopic dermatitis: A retrospective study. J Allergy Clin Immunol Pract. 2019 Sep - Oct; 7(7):2459-2461.
Score: 0.204
-
Psoriasis Features in Patients with Inflammatory Bowel Disease. Open Access Maced J Med Sci. 2019 Mar 30; 7(6):1001-1003.
Score: 0.204
-
Secukinumab and hidradenitis suppurativa: Friends or foes? JAAD Case Rep. 2019 Feb; 5(2):184-187.
Score: 0.202
-
Cutaneous leucocytoclastic vasculitis during secukinumab treatment. Ital J Dermatol Venerol. 2021 12; 156(Suppl. 1 to No. 6):9-10.
Score: 0.201
-
Treatment of Atopic Dermatitis with Biologic Drugs. Dermatol Ther (Heidelb). 2018 Dec; 8(4):527-538.
Score: 0.196
-
Unconventional therapies for hidradenitis suppurativa. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):879-887.
Score: 0.196
-
Adult atopic dermatitis: new and emerging therapies. Expert Rev Clin Pharmacol. 2018 Sep; 11(9):867-878.
Score: 0.195
-
A Case of the Co-Existence of Subcorneal Pustular Dermatosis and Pyoderma Gangrenosum and a Review of the Literature. Open Access Maced J Med Sci. 2018 Jul 20; 6(7):1271-1274.
Score: 0.194
-
Update on pathogenesis of hidradenitis suppurativa. G Ital Dermatol Venereol. 2018 Jun; 153(3 Suppl 2):3-7.
Score: 0.193
-
Hidradenitis suppurativa: from pathogenesis to diagnosis and treatment. Clin Cosmet Investig Dermatol. 2017; 10:105-115.
Score: 0.178
-
Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021 11; 34(6):e15111.
Score: 0.060
-
Dupilumab in adolescents with moderate to severe atopic dermatitis: a 32-week real-world experience during the COVID-19 pandemic. Clin Exp Dermatol. 2022 01; 47(1):165-167.
Score: 0.060
-
Atopic dermatitis in adolescents: Effectiveness and safety of dupilumab in a 16-week real-life experience during the COVID-19 pandemic in Italy. Dermatol Ther. 2021 09; 34(5):e15035.
Score: 0.060
-
Adverse cutaneous and mucous reactions from anti SARS-CoV-2 vaccines: recommendations from the Italian Society of Dermatology (SIDeMaST). Ital J Dermatol Venerol. 2021 Apr; 156(2):115-117.
Score: 0.059
-
May COVID-19 outbreaks lead to a worsening of skin chronic inflammatory conditions? Med Hypotheses. 2020 Oct; 143:109853.
Score: 0.055
-
Intralesional Methotrexate for the Treatment of Keratoacanthoma: The Neapolitan Experience. Dermatol Ther (Heidelb). 2019 Jun; 9(2):369-372.
Score: 0.051
-
Neutrophilic Dermatosis in Pregnancy: An Uncommon Course. Open Access Maced J Med Sci. 2018 Dec 20; 6(12):2393-2394.
Score: 0.050
-
Postinflammatory hypopigmentation due to ferrous sulphate. G Ital Dermatol Venereol. 2020 Apr; 155(2):243-244.
Score: 0.049